摘要
慢性心力衰竭治疗在近20年来已发生重大转变，心衰的治疗目标不仅是改善症状，提高生活质量，更重要的是针对心肌重构的机制，防止和延缓心肌重构的发展。血管紧张素转换酶抑制剂/血管紧张素受体拮抗剂、β受体阻滞剂、醛固酮抑制剂是用于慢性心力衰竭治疗的＂金三角＂药物。近年来临床上已进行或即将开展一些心衰新型药物针对慢性心力衰竭的治疗研究。
The treatment for chronic heart failure has been changed significantly in recent 20 years. Therapeutic target in heart failure not only improves symptoms and quality of life, more important is for the mechanism of myocardial remodeling, prevent and delay the development of myocardial remodeling. Angiotensin converting enzyme inhibitor/angiotensin receptor blockers, beta blockers, and aldosterone inhibitors are used as the ＂golden triangle＂ drug therapy for chronic heart failure. In recent years, it has been or is about to carry out some clinical new drugs for the treatment of chronic heart failure.
出处
《中国医师杂志》
CAS
2016年第7期961-963,共3页
Journal of Chinese Physician
